• ori_banner_01

Awọn API Peptide

  • NMN

    NMN

    Preclinical ati awọn iwadii eniyan ni kutukutu daba NMN le ṣe igbelaruge igbesi aye gigun, ifarada ti ara, ati iṣẹ oye.

    Awọn ẹya API:

    Mimo giga ≥99%

    Elegbogi-ite, o dara fun ẹnu tabi injectable formulations

    Ti ṣelọpọ labẹ awọn iṣedede GMP

    NMN API jẹ apẹrẹ fun lilo ninu awọn afikun egboogi-ti ogbo, awọn itọju ti iṣelọpọ, ati iwadi gigun.

  • Glucagon

    Glucagon

    Glucagon jẹ homonu peptide adayeba ti a lo bi itọju pajawiri fun hypoglycemia ti o lagbara ati iwadi fun ipa rẹ ninu ilana iṣelọpọ, pipadanu iwuwo, ati awọn iwadii ounjẹ ounjẹ.

  • Motixafortide

    Motixafortide

    Motixafortide jẹ peptide antagonist sintetiki ti CXCR4 ti o ni idagbasoke lati ṣe koriya awọn sẹẹli hematopoietic (HSCs) fun gbigbe ara ẹni ati pe o tun n ṣe ikẹkọ ni oncology ati immunotherapy.

  • Glepaglutide

    Glepaglutide

    Glepaglutide jẹ afọwọṣe GLP-2 ti n ṣiṣẹ pipẹ ti o dagbasoke fun itọju iṣọn ifun kukuru (SBS). O mu ki ifun inu ati idagba pọ si, ṣe iranlọwọ fun awọn alaisan dinku igbẹkẹle lori ounjẹ obi.

  • Elamipretide

    Elamipretide

    Elamipretide jẹ tetrapeptide ti o fojusi mitochondria ti o ni idagbasoke lati tọju awọn arun ti o fa nipasẹ ailagbara mitochondrial, pẹlu myopathy mitochondrial akọkọ, iṣọn Barth, ati ikuna ọkan.

     

  • Pegcetacoplan

    Pegcetacoplan

    Pegcetacoplan jẹ peptide cyclic pegylated ti o n ṣe bi oludaniloju ibaramu C3 ti a fojusi, ti o dagbasoke fun itọju awọn aarun ibaramu-alaja gẹgẹbi paroxysmal nocturnal hemoglobinuria (PNH) ati atrophy geographic (GA) ni ibajẹ macular degeneration ti ọjọ-ori.

  • Palopegteriparatide

    Palopegteriparatide

    Palopegteriparatide jẹ agonist olugba homonu parathyroid ti o pẹ (PTH1R agonist), ti o dagbasoke fun itọju hypoparathyroidism onibaje. O jẹ afọwọṣe pegylated ti PTH (1-34) ti a ṣe apẹrẹ lati pese ilana ilana kalisiomu alagbero pẹlu iwọn lilo lẹẹkan-ọsẹ.

  • GHRP-6

    GHRP-6

    GHRP-6 (Homone Growth Releasing Peptide-6) jẹ hexapeptide sintetiki ti o n ṣe bi secretagogue homonu idagba, ti o mu itusilẹ ti ara ti ara ti homonu idagba (GH) ṣiṣẹ nipasẹ mimuuṣiṣẹpọ olugba GHSR-1a.

    Awọn ẹya API:

    Mimo ≥99%

    Ti ṣelọpọ nipasẹ iṣelọpọ peptide ti o lagbara (SPPS)

    Pese fun R&D ati lilo iṣowo

    GHRP-6 jẹ peptide iwadi ti o wapọ fun atilẹyin ti iṣelọpọ, isọdọtun iṣan, ati iyipada homonu.

  • GHRP-2

    GHRP-2

    GHRP-2 (Homone Growth Releasing Peptide-2) jẹ hexapeptide sintetiki ati aṣiri homonu idagba ti o lagbara, ti a ṣe lati ṣe itusilẹ adayeba ti homonu idagba (GH) nipasẹ mimuuṣiṣẹpọ olugba GHSR-1a ni hypothalamus ati pituitary.

    Awọn ẹya API:

    Mimo ≥99%

    Wa fun R&D ati ipese iṣowo, pẹlu iwe kikun QC

    GHRP-2 jẹ peptide iwadii ti o niyelori ni awọn aaye ti endocrinology, oogun isọdọtun, ati awọn itọju ti ọjọ-ori.

  • Hexarelin

    Hexarelin

    Hexarelin jẹ homonu idagba sintetiki peptide secretagogue (GHS) ati GHSR-1a agonist ti o lagbara, ti o dagbasoke lati ṣe itusilẹ homonu idagba endogenous (GH). O jẹ ti idile mimetic ghrelin ati pe o ni awọn amino acids mẹfa (hexapeptide kan), ti o funni ni iduroṣinṣin ti iṣelọpọ agbara ati awọn ipa itusilẹ GH ti o lagbara ni akawe si awọn afọwọṣe iṣaaju bii GHRP-6.

    Awọn ẹya API:

    Mimọ ≥ 99%

    Ti ṣejade nipasẹ iṣelọpọ peptide ti o lagbara (SPPS)

    Awọn iṣedede GMP, kekere endotoxin ati awọn iṣẹku olomi

    Ipese iyipada: R&D si iwọn iṣowo

  • Melanotan II

    Melanotan II

    Awọn ẹya API:
    Mimo giga ≥ 99%
    Ṣepọpọ nipasẹ iṣelọpọ peptide ti o lagbara (SPPS)
    Kekere endotoxin, awọn olomi aloku kekere
    Wa ni R&D si iwọn iṣowo

  • Melanotan 1

    Melanotan 1

    Melanotan 1 API jẹ iṣelọpọ ni lilo imọ-ẹrọ peptide alakoso to lagbara (SPPS) labẹ awọn ipo iṣakoso didara GMP ti o muna.

    • Mimo giga ≥99%

    • Iṣajọpọ peptide alakoso-lile (SPPS)

    • GMP-bi ẹrọ awọn ajohunše

    • Iwe kikun: COA, MSDS, data iduroṣinṣin

    • Ipese iwọn: R&D si awọn ipele iṣowo

<< 1234Itele >>> Oju-iwe 2/4